Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and qemcitabine

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Abstract

A patient with stage IV malignant melanoma treated with daily radiotherapy and low-dose (100 mg/m2) daily gemcitabine developed a blistering skin eruption, fever and neutropenia consistent with overlap Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). The diagnosis was confirmed by skin biopsy of an affected area. The case history is described, and the literature relating to the development of SJS/TEN in association with chemotherapy and radiotherapy administration is reviewed. This report describes a serious potential complication of concurrent gemcitabine and radiotherapy.

Original languageEnglish
Pages (from-to)659-662
Number of pages4
JournalAnti-Cancer Drugs
Volume14
Issue number8
DOIs
StatePublished - Sep 2003
Externally publishedYes

Keywords

  • Chemotherapy toxicity
  • Gemcitabine
  • Radiation
  • Stevens-Johnson Syndrome
  • Toxic epidermal necrolysis

Fingerprint

Dive into the research topics of 'Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and qemcitabine'. Together they form a unique fingerprint.

Cite this